Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 21;14(6):100549.
doi: 10.1016/j.waojou.2021.100549. eCollection 2021 Jun.

Algorithm to guide re-exposure to penicillin in allergic pregnant women with syphilis: Efficacy and safety

Affiliations

Algorithm to guide re-exposure to penicillin in allergic pregnant women with syphilis: Efficacy and safety

Juliana Fóes Bianchini Garcia et al. World Allergy Organ J. .

Abstract

Background: Gestational syphilis is underdiagnosed and undertreated, leading to stillbirth, prematurity, low birthweight, neonatal death, and congenital syphilis. Most patients who label as allergic to penicillin are misdiagnosed.

Objective: To assess the efficacy and safety of an algorithm to guide re-exposure to penicillin in pregnant women with syphilis and reporting allergy to the antibiotic.

Methods: We performed a prospective study assessing pregnant women with syphilis and labeled as allergic to penicillin. Based on clinical history, patients were divided in two groups: high-risk and low-risk to penicillin allergy. Low-risk patients with negative skin testing and negative serum specific IgE to penicillin underwent drug provocation test. The remaining patients underwent desensitization.

Results: Ninety-one patients were enrolled. Allergy to penicillin was confirmed in 7.69% of pregnant women with syphilis and clinical history of allergy to penicillin; in all cases the diagnosis was made through intradermal testing, which predicted 100% of the breakthrough reactions observed during rapid drug desensitization (p < 0.001). Risk stratification based on the initial clinical reaction and skin testing to guide penicillin re-introduction through drug challenge or desensitization was safe (97.8%) and effective (97.8%).

Conclusion: We developed and showed the efficacy and safety of an algorithm to guide re-exposure to penicillin in pregnant women with syphilis and labeled as allergic to this drug. Intradermal test is an excellent biomarker in the diagnosis of immediate hypersensitivity reaction to penicillin and to predict breakthrough reaction during rapid drug desensitization. Further studies may confirm the greater safety of the intravenous protocol compared to the oral protocol.

Keywords: Algorithm; Anaphylaxis; Benzathine penicillin; Congenital syphilis; Desensitization; Gestational syphilis; Immediate hypersensitivity reactions; Pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors have no financial or conflicts of interest to disclosure. All authors participated in the design of the present study and in the analysis of its results. Juliana F. B. Garcia and Pedro Giavina-Bianchi collected the data and wrote the manuscript. All authors read, approved and consented to the publication of this manuscript.

Figures

Fig. 1
Fig. 1
Algorithm for evaluation and management of beta-lactam allergy in pregnant women with syphilis. Footnote: ∗ Tests not performed in the present study. sIgE: serum specific IgE BAT: basophil activation test. Adapted from Giavina-Bianchi P et al. J Allergy Clin Immunol Pract. 2017; 5(3):593-9(18)
Fig. 2
Fig. 2
Risk stratification, procedures and outcomes. Footnote: sIgE: serum specific IgE IHR: immediate hypersensitivity reaction
Fig. 3
Fig. 3
Number of patients according criteria for high-risk to penicillin allergy. Footnote: IHR: immediate hypersensitivity reaction
Fig. 4
Fig. 4
Clinical manifestations of the initial immediate hypersensitivity reaction
Fig. S1
Fig. S1
Oral desensitization protocol. Footnote: Adapted from the protocol described by Wendel GD Jr et al. N Engl J Med 1985; 312: 1229-32(19).
Fig. S2
Fig. S2
Intravenous desensitization protocol. Division of Clinical Immunology and Allergy. Footnote: Adapted from the protocol described by Castells MC et al. J Allergy Clin Immunol 2008; 122: 574-80(20).

Similar articles

Cited by

References

    1. Nelson R. Congenital syphilis and other STIs rise in the USA. Lancet Infect Dis. 2018;18(11):1186–1187. - PubMed
    1. Tsai S., Sun M.Y., Kuller J.A., Rhee E.H.J., Dotters-Katz S. Syphilis in pregnancy. Obstet Gynecol Surv. 2019;74(9):557–564. - PubMed
    1. Lin J.S., Eder M.L., Bean S.I. Screening for syphilis infection in pregnant women: updated evidence report and systematic review for the US preventive services task force. J Am Med Assoc. 2018;320(9):918–925. - PubMed
    1. Storey A., Seghers F., Pyne-Mercier L., Peeling R.W., Owiredu M.N., Taylor M.M. Syphilis diagnosis and treatment during antenatal care: the potential catalytic impact of the dual HIV and syphilis rapid diagnostic test. Lancet Glob Health. 2019;7(8):e1006–e1008. - PMC - PubMed
    1. Trinh T., Leal A.F., Mello M.B. Syphilis management in pregnancy: a review of guideline recommendations from countries around the world. Sex Reprod Health Matters. 2019;27(1):69–82. - PMC - PubMed

LinkOut - more resources